GENERAL ATLANTIC, L.P. - CINCOR PHARMA INC ownership

Back to all holdings Add to watchlist

CINCOR PHARMA INC's ticker is and the CUSIP is 17240Y109. A total of 87 filers reported holding CINCOR PHARMA INC in Q3 2022. The put-call ratio across all filers is 4.10 and the average weighting 0.9%.

Links
Filings
Quarter-by-quarter ownership
GENERAL ATLANTIC, L.P. ownership history of CINCOR PHARMA INC
ValueSharesWeighting
Q4 2022$51,734,386
-62.6%
4,209,4700.0%0.68%
-57.9%
Q3 2022$138,155,000
+77.7%
4,209,470
+2.0%
1.63%
+60.3%
Q2 2022$77,743,000
+7.4%
4,126,4700.0%1.02%
+53.3%
Q1 2022$72,378,000–4,126,470–0.66%–
 Download
Other shareholders
CINCOR PHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
5AM Venture Management, LLC 4,937,646$60,683,66916.31%
Sofinnova Investments, Inc. 6,073,949$74,648,8334.43%
Omega Fund Management, LLC 560,985$7,853,7902.65%
GREAT POINT PARTNERS LLC 1,019,153$12,525,3902.46%
venBio Partners LLC 383,390$4,711,8631.46%
Cheyne Capital Management (UK) LLP 67,557$830,2761.45%
SPHERA FUNDS MANAGEMENT LTD. 529,640$6,509,2761.40%
SILVERARC CAPITAL MANAGEMENT, LLC 395,382$4,859,2451.39%
Perceptive Advisors 2,576,325$31,663,0340.89%
AlphaCentric Advisors LLC 70,000$860,3000.85%
View complete list of CINCOR PHARMA INC shareholders